ANI Pharmaceuticals (Germany) Market Value
BSFA Stock | 51.00 0.00 0.00% |
Symbol | ANI |
ANI Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ANI Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ANI Pharmaceuticals.
02/06/2023 |
| 12/27/2024 |
If you would invest 0.00 in ANI Pharmaceuticals on February 6, 2023 and sell it all today you would earn a total of 0.00 from holding ANI Pharmaceuticals or generate 0.0% return on investment in ANI Pharmaceuticals over 690 days. ANI Pharmaceuticals is related to or competes with Merck KGaA, Haleon PLC, LIVZON PHARMAC, SIMCERE PHARMAC, CanSino Biologics, Evotec SE, and Dermapharm Holding. More
ANI Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ANI Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ANI Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.05) | |||
Maximum Drawdown | 9.18 | |||
Value At Risk | (3.30) | |||
Potential Upside | 3.41 |
ANI Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ANI Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ANI Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use ANI Pharmaceuticals historical prices to predict the future ANI Pharmaceuticals' volatility.Risk Adjusted Performance | (0.01) | |||
Jensen Alpha | (0.03) | |||
Total Risk Alpha | (0.16) | |||
Treynor Ratio | 0.1544 |
ANI Pharmaceuticals Backtested Returns
ANI Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0213, which signifies that the company had a -0.0213% return per unit of return volatility over the last 3 months. ANI Pharmaceuticals exposes eighteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ANI Pharmaceuticals' Risk Adjusted Performance of (0.01), coefficient of variation of (5,233), and Mean Deviation of 1.56 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.31, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning ANI Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, ANI Pharmaceuticals is likely to outperform the market. At this point, ANI Pharmaceuticals has a negative expected return of -0.0425%. Please make sure to confirm ANI Pharmaceuticals' information ratio, maximum drawdown, and the relationship between the variance and jensen alpha , to decide if ANI Pharmaceuticals performance from the past will be repeated in the future.
Auto-correlation | -0.47 |
Modest reverse predictability
ANI Pharmaceuticals has modest reverse predictability. Overlapping area represents the amount of predictability between ANI Pharmaceuticals time series from 6th of February 2023 to 17th of January 2024 and 17th of January 2024 to 27th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ANI Pharmaceuticals price movement. The serial correlation of -0.47 indicates that about 47.0% of current ANI Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.47 | |
Spearman Rank Test | -0.17 | |
Residual Average | 0.0 | |
Price Variance | 14.03 |
ANI Pharmaceuticals lagged returns against current returns
Autocorrelation, which is ANI Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ANI Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of ANI Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that ANI Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
ANI Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ANI Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ANI Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ANI Pharmaceuticals stock over time.
Current vs Lagged Prices |
Timeline |
ANI Pharmaceuticals Lagged Returns
When evaluating ANI Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ANI Pharmaceuticals stock have on its future price. ANI Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ANI Pharmaceuticals autocorrelation shows the relationship between ANI Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in ANI Pharmaceuticals.
Regressed Prices |
Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ANI Stock Analysis
When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.